Detection Technology

DT’s Q1 revenue was slightly higher than we estimated, while EBITA was in line. We make only small downward estimate revisions as Q2 outlook is a bit softer than we expected, but we continue to expect close to 10% growth for FY’26.

DT’s Q1 figures matched estimates as EBITA improved by EUR 1m y/y to EUR 2.4m. Many growth drivers are now working favorably for DT, and growth is expected to continue at least for the next two quarters.

DT reports Q1 results on Apr 23. It shouldn’t take more than to maintain last year’s rather low EBITA level to see gains, and in the base case of some growth upside is already meaningful.

DT’s outlook is turning much brighter now as security CT volumes are recovering after the slump seen last year.

DT’s Q4 results were largely in line with estimates as revenue declined by 6% y/y while EBITA was down EUR 1.5m to EUR 3.7m. Security applications declined even more than we estimated while medical was clearly stronger, leading DT’s figures very close...

DT reports Q4 results on Feb 5. Last year was challenging, but now Q1’26 should see double-digit growth; a similar pace could continue in Q2 and beyond, in which case earnings multiples would start to look quite cheap soon enough.